Bulgaria’s lack of cancer biomarker funding prompts discrimination complaint [Advocacy Lab]
Patient groups argue that the absence of publicly funded biomarker testing is excluding those unable to pay for access to life-saving personalised cancer therapies
المصدر: EURACTIV
0
مشاهدة